Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Continuous Insulin Infusion System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00291772
What this trial is testing

Continuous Subcutaneous Infusion of Pramlintide and Insulin

Who this might be right for
Type 1 Diabetes
Baylor College of Medicine 13
Post-approval studies (Phase 4)UnknownNCT01574508
What this trial is testing

Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy

Who this might be right for
Type 2 Diabetes
Shanghai Jiao Tong University School of Medicine 120
Post-approval studies (Phase 4)Study completedNCT01848990
What this trial is testing

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

Who this might be right for
Type 1 Diabetes Mellitus
Halozyme Therapeutics 456
Not applicableStudy completedNCT02129868
What this trial is testing

Automated Closed-loop in Children and Adolescents With Type 1 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 1Glucose Metabolism Disorders+2 more
University of Cambridge 13
Post-approval studies (Phase 4)Study completedNCT05677334
What this trial is testing

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

Who this might be right for
Type2diabetes
First Affiliated Hospital of Guangxi Medical University 210
Not applicableStudy completedNCT03748251
What this trial is testing

Management of Glycemia Following a Pizza Meal

Who this might be right for
Diabetes Mellitus, Type 1
University of Campania Luigi Vanvitelli 38
Not applicableStudy completedNCT01104142
What this trial is testing

Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy

Who this might be right for
Type 1 Diabetes Mellitus
DexCom, Inc. 120
Post-approval studies (Phase 4)Study completedNCT01400659
What this trial is testing

Pizza-Salami Study in Children and Adolescents With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Kinderkrankenhaus auf der Bult 42
Not applicableUnknownNCT05201846
What this trial is testing

Comparison of CSII and MDI in Pediatric Patients With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Seoul National University Hospital 66
Not applicableStudy completedNCT00147836
What this trial is testing

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Sun Yat-sen University 436
Not applicableStudy completedNCT04258904
What this trial is testing

Prevention of Skin Problems With Diabetes Devices in Pediatric Patients

Who this might be right for
Type 1 DiabetesDermatologic Complication
Copenhagen University Hospital at Herlev 236
Large-scale testing (Phase 3)Study completedNCT01550809
What this trial is testing

New Strategies for Postprandial Glycemic Control Using Insulin Pump Therapy

Who this might be right for
Type 1 Diabetes
Fundación para la Investigación del Hospital Clínico de Valencia 12
Early research (Phase 1)Study completedNCT04276207
What this trial is testing

LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 32
Early research (Phase 1)Study completedNCT03436498
What this trial is testing

Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients

Who this might be right for
Type 1 Diabetes Mellitus
Sanofi 45
Early research (Phase 1)Study completedNCT05184868
What this trial is testing

AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study

Who this might be right for
Diabetes Mellitus, Type 1
Arecor Limited 24
Large-scale testing (Phase 3)Study completedNCT00046150
What this trial is testing

12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.

Who this might be right for
Diabetes, Type I
Sanofi 59
Not applicableUnknownNCT04939766
What this trial is testing

Impact of the Use of a Closed-loop Insulin Therapy on the Burden of the Diabetes and the Quality of Life

Who this might be right for
Quality of LifeBurden, Dependency
VitalAire 250
Post-approval studies (Phase 4)Study completedNCT00462371
What this trial is testing

Comparison Between Insulin Pump Treatment and Multiple Daily Insulin Injections in Diabetic Type 1 Children

Who this might be right for
Diabetes Mellitus, Type 1Child
Erasmus Medical Center 38
Post-approval studies (Phase 4)Study completedNCT00859079
What this trial is testing

Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus Type 2Hyperglycemia
Medical University of Graz 8
Testing effectiveness (Phase 2)Study completedNCT01666028
What this trial is testing

Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Cambridge 18
Next Page